Study protocol: azithromycin therapy for chronic lung disease of prematurity (AZTEC) - a randomised, placebo-controlled trial of azithromycin for the prevention of chronic lung disease of prematurity in preterm infants

INTRODUCTION: Chronic lung disease of prematurity (CLD), also known as bronchopulmonary dysplasia (BPD), is a cause of significant respiratory morbidity in childhood and beyond. Coupled with lung immaturity, infections (especially by Ureaplasma spp) are implicated in the pathogenesis of CLD through...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:BMJ Open
Egile Nagusiak: Lowe, John, Gillespie, David, Hubbard, Marie, Zhang, Lei, Kirby, Nigel, Pickles, Timothy, Thomas-Jones, Emma, Turner, Mark A, Klein, Nigel, Marchesi, Julian R, Hood, Kerenza, Berrington, Janet, Kotecha, Sailesh
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BMJ Publishing Group 2020
Gaiak:
Respiratory Medicine
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7539578/
https://ncbi.nlm.nih.gov/pubmed/33028566
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2020-041528
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak